CACrown ArchivesThe cinema collection
Menu
Research dossier · Science & Nature

Galectin-4

protein-coding gene in the species Homo sapiens

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 11, 2026
Entity authorityQ18028534
Source-derived summary

Galectin-4 is a protein that in humans is encoded by the LGALS4 gene.

The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS4 is an S-type lectin that is strongly underexpressed in colorectal cancer. The 323-amino acid LGALS4 protein contains two homologous, approximately 150-amino acid carbohydrate recognition domains and all amino acids typically conserved in galectins.

Nomenclature

Recommended name:Galectin-4, Short name: Gal-4 Alternative name(s):

Antigen NY-CO-27

L-36 lactose-binding protein, Short name: L36L

Lactose-binding lectin 4

Tissue distribution

Gal-4 is highly expressed in the stomach and intestine.

Structure

Gal 4 belongs to the family of galectin. Among various structure of galectins like dimeric, tandem or chimera, Gal-4 is tandem in its structure, so they contains at least two distinct carbohydrate recognising domains (CRD) within one polypeptide, thus are said to be intrinsically divalent. The CRDs are linked with a small peptide domain.

Function

Gal-4 has binding ability with high affinity to lipid rafts suggesting a role in protein delivery to cells

Plus they can perform the following Physiological functions:

Gal-4 enhances the stabilization of lipid raft

Gal-4 participates in apical trafficking

Gal-4 has bactericidal activity against bacteria expressing blood group antigen

Gal-4 promotes intestinal wound healing

Gal-4 promotes growth of axon and myelination in neuron

Clinical significance

Cancer

Gal-4 which has been detected in many cancer has involved in association with the development and sequence of pancreatic carcinoma, hepatocellular carcinoma, Colorectal cancer (CRC), breast carcinoma, gastric cancer, and lung cancer (Rechreche et al., 1997; Hippo et al., 2001; Hayashi et al., 2013; Belo et al., 2013; Cai et al., 2014). After all, it plays contradictory roles in different type of cancer cell.

Editorial summary

Begin with the source’s own compact description: “Galectin-4” is protein-coding gene in the species Homo sapiens. The dossier treats that line as a proposition to test through Galectin-4, protein-coding and gene, not as a finished interpretation.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current lead gives the account dated anchors—1997, 2001, 2013, 2014—that can be checked directly. The selected authority fields contribute no independent date. For this dossier, Galectin-4, protein-coding and gene is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “protein-coding gene in the species Homo sapiens” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Sep 11, 2026. The linked authority identifier is Q18028534. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1997, 2001, 2013 and 2014.

Critical limits

Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Galectin-4”, its source revision and the description used here.
  2. Expand the search: follow Galectin-4 primary sources, Galectin-4 archive and Galectin-4 research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Galectin-4”?
  2. Has classification or technical consensus changed since the cited source?
  3. Is the terminology current, historical or disputed?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Galectin-4” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.